Influenza, Human
Showing 26 - 50 of 175
Influenza, Human, COVID-19 Trial in United States (bivalent BNT162b2 (original/Omi BA.4/BA.5), qIRV (22/23), QIV)
Recruiting
- Influenza, Human
- COVID-19
- bivalent BNT162b2 (original/Omi BA.4/BA.5)
- +2 more
-
Athens, Alabama
- +18 more
Dec 22, 2022
Influenza, Human Trial in Birmingham (Treatment Group Live Attenuated Flu Vaccine (LAIV))
Completed
- Influenza, Human
- Treatment Group Live Attenuated Flu Vaccine (LAIV)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 16, 2022
Influenza, Human Trial in Philadelphia (Seasonal influenza vaccine)
Recruiting
- Influenza, Human
- Seasonal influenza vaccine
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 17, 2022
Does Repeat Influenza Vaccination Constrain Influenza Immune
Recruiting
- Influenza, Human
- SARS-CoV-2 Infection
- Influenza vaccination: Fluarix Tetra, Vaxigrip Tetra, Fluquadri, Fluad Quad, Afluia Quad, Flucelvax Quad
- SARS-CoV-2 vaccination: Comirnaty or Vaxzevria
-
New Lambton Heights, New South Wales, Australia
- +5 more
Nov 7, 2022
Influenza, Human Trial in United States (NanoFlu (Quad-NIV), Matrix-M Adjuvant, Placebo)
Terminated
- Influenza, Human
- NanoFlu (Quad-NIV)
- +5 more
-
Hollywood, Florida
- +13 more
Nov 3, 2022
Influenza, Human Trial (Clarithromycin 250 MG, Placebos)
Suspended
- Influenza, Human
- Clarithromycin 250 MG
- Placebos
-
Hong Kong, Hong KongSchool of Public Health, The University of Hong Kong
Nov 1, 2022
Influenza, Human Trial in United States (Quadrivalent influenza modRNA vaccine, Quadrivalent influenza vaccine)
Recruiting
- Influenza, Human
- Quadrivalent influenza modRNA vaccine
- Quadrivalent influenza vaccine
-
Athens, Alabama
- +92 more
Sep 15, 2022
Influenza, Human Trial (Fluzone Quadrivalent, Flublok Quadrivalent)
Not yet recruiting
- Influenza, Human
- Fluzone Quadrivalent
- Flublok Quadrivalent
- (no location specified)
Aug 22, 2022
Influenza, Human Trial in Sacramento (Procalcitonin, Pharmacist-Led Education)
Completed
- Influenza, Human
- Procalcitonin
- Pharmacist-Led Education
-
Sacramento, CaliforniaUniversity of California, Davis Medical Center
Aug 16, 2022
Influenza, Human Trial in United States (mIRV, bIRV AB, qIRV)
Recruiting
- Influenza, Human
- mIRV
- +5 more
-
Athens, Alabama
- +97 more
Aug 16, 2022
Influenza, Human Trial in United States (Experimental: IIV-A Investigational IIV-A will be administered as a single dose
Not yet recruiting
- Influenza, Human
- Experimental: IIV-A Investigational IIV-A will be administered as a single dose intramuscularly on Day 1
- +3 more
-
Tempe, Arizona
- +44 more
Aug 16, 2022
Influenza, Human, Respiratory Syncytial Virus Infections Trial in United States (Swab)
Recruiting
- Influenza, Human
- Respiratory Syncytial Virus Infections
- Swab
-
Birmingham, Alabama
- +19 more
Aug 16, 2022
Evaluation of Humoral Immunity Following COVID-19 in Pregnancy
Active, not recruiting
- COVID-19
- +2 more
- Blood sample
-
London, United Kingdom
- +1 more
Aug 8, 2022
Influenza, Human Trial in Feicheng City (Quadrivalent Influenza Virus Split Vaccine)
Recruiting
- Influenza, Human
- Quadrivalent Influenza Virus Split Vaccine
-
Feicheng City, Shandong, ChinaTingting and Yu
Aug 3, 2022
Influenza, Human, Pneumonia, Pneumococcal Trial in Quanzhou, Qingzhen, Qidong (IIV4 and PPV23, IIV4, PPV23)
Completed
- Influenza, Human
- Pneumonia, Pneumococcal
- IIV4 and PPV23
- +2 more
-
Quanzhou, Fujian, China
- +3 more
Aug 1, 2022
Influenza, Human, Influenza in Birds, Respiratory Tract Infections Trial in United States (aH5N6c on Day 1, aH5N6c on Day 22,
Recruiting
- Influenza, Human
- +7 more
- aH5N6c on Day 1
- +2 more
-
Huntsville, Alabama
- +17 more
Jul 26, 2022
Influenza, Human Trial in Estonia, Germany, United States (aQIV, Comparator QIV)
Active, not recruiting
- Influenza, Human
- aQIV
- Comparator QIV
-
Mobile, Alabama
- +28 more
Jul 26, 2022
Influenza, Human, Vaccination; Infection, Vaccines Trial in Saint Petersburg (Flu-M, Inactivated split influenza vaccine 0.5 mL,
Completed
- Influenza, Human
- +2 more
- Flu-M, Inactivated split influenza vaccine 0.5 mL
- +3 more
-
Saint Petersburg, Russian Federation
- +1 more
Jul 19, 2022
Influenza, Human Trial in Estonia, Philippines (H5N1 antigen combined with MF59 adjuvant)
Completed
- Influenza, Human
- H5N1 antigen combined with MF59 adjuvant
-
Tallinn, Harjumaa, Estonia
- +6 more
Jul 21, 2022
Influenza, Human, Transplantation Infection Trial in Falls Church (influenza trivalent inactive vaccine, influenza trivalent
Completed
- Influenza, Human
- Transplantation Infection
- influenza trivalent inactive vaccine
- influenza trivalent inactive vaccine high dose
-
Falls Church, VirginiaInova Fairfax Hospital
Jul 20, 2022
Influenza, Human, Vaccination; Infection, Vaccines Trial in Russian Federation (Flu-M, Inactivated split influenza vaccine,
Completed
- Influenza, Human
- +2 more
- Flu-M, Inactivated split influenza vaccine
- Ultrix®, Inactivated Split Influenza Vaccine
-
Barnaul, Altai Territory, Russian Federation
- +4 more
Jul 11, 2022
Respiratory Syncytial Virus Infections, Influenza, Human Trial in London (RSV A Memphis 37, Influenza A/California/04/2009)
Terminated
- Respiratory Syncytial Virus Infections
- Influenza, Human
- RSV A Memphis 37
- Influenza A/California/04/2009
-
London, United KingdomNational Heart and Lung Institute, Imperial College London
Jun 23, 2022
Influenza, Human Trial in Morayfield (CODA-VAX H1N1, Flucelvax Quad, Saline)
Active, not recruiting
- Influenza, Human
- CODA-VAX H1N1
- +2 more
-
Morayfield, Queensland, AustraliaAmy Goh, Study Coordinator
Jun 24, 2022
Influenza, Influenza, Human, Influenza -Like Illness Trial in Norfolk (Oseltamivir, Baloxavir)
Recruiting
- Influenza
- +2 more
-
Norfolk, VirginiaInsight Therapeutics, LLC
Jun 14, 2022